Epigenetic treatment of neurological disease.

Epigenetic treatment of neurological disease.

Item
http://www.wikidata.org/entity/Q37962584
Class I lysine deacetylases promote glucocorticoid-induced transcriptional repression through functional interaction with LSD1.Correlation of Alzheimer's disease death rates with historical per capita personal income in the USATherapeutic perspectives of epigenetically active nutrients.Histone deacetylase complexes as caretakers of genome stability.Combination therapy: histone deacetylase inhibitors and platinum-based chemotherapeutics for cancerPerspectives on epigenetic-based immune intervention for rheumatic diseases.Epigenetic biomarkers in laboratory diagnostics: emerging approaches and opportunities.Small-molecule inhibitors of histone deacetylase for the treatment of cancer and non-cancer diseases: a patent review (2011 - 2013).Epigenetic-based immune intervention for rheumatic diseases.Emerging approaches for histone deacetylase inhibitor drug discovery.A chemical strategy for the cell-based detection of HDAC activity.Potential Synergies of β-Hydroxybutyrate and Butyrate on the Modulation of Metabolism, Inflammation, Cognition, and General Health.
P2860

Epigenetic treatment of neurological disease.

Item
http://www.wikidata.org/entity/Q37962584
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epigenetic treatment of neurological disease.
@en
Epigenetic treatment of neurological disease.
@nl
type
label
Epigenetic treatment of neurological disease.
@en
Epigenetic treatment of neurological disease.
@nl
prefLabel
Epigenetic treatment of neurological disease.
@en
Epigenetic treatment of neurological disease.
@nl
P1433
P1476
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Epigenetic treatment of neurological disease.
@en
P2860
P304
P31
P356
P433
P478
P50
P577
P698